Shedding of NKG2D ligands, including MICA, MICB and ULBP2, is inhibited by TIMP-3 in acute myeloid leukemia (AML) cells, and this process enhances their sensitivity to lytic activity of NK [118]. Here, MICB is linked to acute myeloid leukemia.